Barr Pharmaceuticals Inc (NYSE:BRL) to Present at Morgan Stanley Global Healthcare Unplugged Conference September 9

Barr Pharmaceuticals, Inc (NYSE:BRL) will speak at the Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9 at 2:10 pm ET.  A webcast of the presentation will be avaialabe on the Calendar of Events of the company’s Investor Relations page at barrlabs.com/investors/index.php.

Barr Pharmaceuticals, Inc. (Barr) is a holding company. Through its subsidiaries, the Company operates as a global specialty pharmaceutical company with operations in more than 30 countries.

Through its principal subsidiaries, Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. (Duramed) and PLIVA d.d. (PLIVA), the Company is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. Barr is also involved in the development of generic biologic products.

The Company operates in two business segments: generic pharmaceuticals and proprietary pharmaceuticals. Barr’s generic product portfolio includes solid oral dosage forms, injectables, liquids and cream/ointment products. It markets and sells generic pharmaceutical products in the United States, Europe and certain other countries in the rest of the world (ROW). The Company’s proprietary product portfolio and pipeline is largely concentrated in the area of female healthcare.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals.  The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies.

The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.

Create your profile on The Global Market Directory.